← All trials
NCT00523965
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2007
- Primary completion
- Aug 1, 2009
- Completion date
- Feb 1, 2010
- First posted
- —
- Last posted
- —
- Enrollment
- 624
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- Banaras Hindu UniversityLead sponsor
- Rajendra Memorial Research Institute of Medical SciencesOverall official - principal investigator
- Rajendra Memorial Research Institute of Medical SciencesCollaborator
- Banaras Hindu UniversityOverall official - principal investigator
- Drugs for Neglected Diseases InitiativeCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.